Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of a Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment: A Randomized Controlled Trial

NCT06686823 is registered in ClinicalTrials.gov with University of Salamanca as lead sponsor.

NCT NCT06686823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06686823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of a Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment: A Randomized Controlled Trial
Lead sponsor
University of Salamanca
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2024
Completion date
October 1, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cancer-related cognitive impairment, clinical trials, cognitive training, everyday cognition, oncology